BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2742731)

  • 1. Cognitive disturbances in Parkinson's disease.
    Beatty WW; Staton RD; Weir WS; Monson N; Whitaker HA
    J Geriatr Psychiatry Neurol; 1989; 2(1):22-33. PubMed ID: 2742731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability.
    Cooper JA; Sagar HJ; Jordan N; Harvey NS; Sullivan EV
    Brain; 1991 Oct; 114 ( Pt 5)():2095-122. PubMed ID: 1933236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairments in different stages of Parkinson's disease.
    Starkstein SE; Bolduc PL; Preziosi TJ; Robinson RG
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):243-8. PubMed ID: 2521068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problem solving in Parkinson's disease: comparison of performance on the Wisconsin and California Card Sorting Tests.
    Beatty WW; Monson N
    J Geriatr Psychiatry Neurol; 1990; 3(3):163-71. PubMed ID: 2282133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed.
    Beats BC; Sahakian BJ; Levy R
    Psychol Med; 1996 May; 26(3):591-603. PubMed ID: 8733217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and cortical thinning patterns of subjective cognitive decline in patients with and without Parkinson's disease.
    Hong JY; Yun HJ; Sunwoo MK; Ham JH; Lee JM; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2014 Sep; 20(9):999-1003. PubMed ID: 25001316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
    Cammisuli DM; Sportiello MT
    Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Procedural learning and Parkinson disease: implication of striato-frontal loops].
    Sarazin M; Deweer B; Pillon B; Merkl A; Dubois B
    Rev Neurol (Paris); 2001 Dec; 157(12):1513-8. PubMed ID: 11924447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease.
    Brown GG; Rahill AA; Gorell JM; McDonald C; Brown SJ; Sillanpaa M; Shults C
    J Geriatr Psychiatry Neurol; 1999; 12(4):180-8. PubMed ID: 10616865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective deficits in cognition and memory in high-functioning parkinsonian patients.
    Mohr E; Juncos J; Cox C; Litvan I; Fedio P; Chase TN
    J Neurol Neurosurg Psychiatry; 1990 Jul; 53(7):603-6. PubMed ID: 2391526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of neuropsychological change in individuals with Parkinson's disease.
    Azuma T; Cruz RF; Bayles KA; Tomoeda CK; Montgomery EB
    Int J Geriatr Psychiatry; 2003 Dec; 18(12):1115-20. PubMed ID: 14677144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological impairments associated with severity of Parkinson's disease.
    Huber SJ; Freidenberg DL; Shuttleworth EC; Paulson GW; Christy JA
    J Neuropsychiatry Clin Neurosci; 1989; 1(2):154-8. PubMed ID: 2521056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognition in a patient with very mild right-sided hemiparkinsonism.
    Beatty WW
    Neurocase; 2002; 8(1-2):28-39. PubMed ID: 11997483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive deficits in the early stages of Parkinson's disease.
    Lees AJ; Smith E
    Brain; 1983 Jun; 106 (Pt 2)():257-70. PubMed ID: 6850270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic effects on cognitive performance in patients with Parkinson's disease.
    Lange KW; Paul GM; Naumann M; Gsell W
    J Neural Transm Suppl; 1995; 46():423-32. PubMed ID: 8821078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
    Souza CP; Oliveira GN; Foss MP; Tumas V
    J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computerized testing in Parkinson's disease: Performance deficits in relation to standard clinical measures.
    Flannery SL; Jowett T; Garvey A; Cutfield NJ; Machado L
    J Clin Exp Neuropsychol; 2018 Dec; 40(10):1062-1073. PubMed ID: 29978753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in Parkinson's disease: more than a frontostriatal dysfunction.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    Span J Psychol; 2014 Oct; 17():E68. PubMed ID: 26054917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.